WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.87 CNY | +0.41% |
|
-1.22% | -23.91% |
| 20/05 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
| 08/05 | US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 411M | - | - | - | - | - | |
| 41.97B | ||||||
| 22.34B | ||||||
| 15.25B | ||||||
| 14B | ||||||
| 12.06B |
